STOCK TITAN

Zimmer Biomet (NYSE: ZBH) exec vests 9,957 RSUs, with 4,266 shares withheld

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ZIMMER BIOMET HOLDINGS executive Kevin R. Thornal exercised 9,957 Restricted Stock Units into 9,957 shares of common stock on August 1, 2026. To satisfy tax obligations on this RSU vesting, 4,266 shares were withheld at $92.68 per share. Following the transaction, Thornal held 19,913 RSUs, with the remaining units scheduled to vest half on August 1, 2027 and half on August 1, 2028.

Positive

  • None.

Negative

  • None.
Insider Thornal Kevin R
Role Grp Pres-Global Business
Type Security Shares Price Value
Exercise Restricted Stock Units F2, F3 9,957 $0.00 $0.00
Exercise Common Stock 9,957 $0.00 $0.00
Tax Withholding Common Stock F1 4,266 $92.68 $395K
Holdings After Transaction: Restricted Stock Units — 19,913 shares (Direct); Common Stock — 5,691 shares (Direct)
Footnotes (3)
  1. F1. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
  2. F2. Each RSU represents a contingent right to receive one share of Company common stock.
  3. F3. One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028.
RSUs converted 9957.0000 units Restricted Stock Units converted into common stock on August 1, 2026
Common shares acquired from RSUs 9957.0000 shares Shares of common stock received upon RSU vesting and conversion on August 1, 2026
Shares withheld for taxes 4266.0000 shares Common shares withheld to satisfy tax withholding obligations on RSU vesting
Tax withholding price 92.6800 per share Per-share value used for shares withheld for tax obligations
RSUs remaining after transaction 19913.0000 units Restricted Stock Units held after August 1, 2026 vesting event
Restricted Stock Units financial
"security title "Restricted Stock Units" reported for the RSUs"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"shares withheld by the Company to satisfy tax withholding obligations"
contingent right financial
"Each RSU represents a contingent right to receive one share"
vesting financial
"One-third of the RSUs vested on August 1, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider activity did Kevin R. Thornal report for Zimmer Biomet (ZBH)?

Kevin R. Thornal reported exercising 9,957 Restricted Stock Units into 9,957 shares of Zimmer Biomet common stock. To cover tax obligations from this vesting, 4,266 shares were withheld by the company at a price of $92.68 per share.

How many ZBH Restricted Stock Units vested and converted to common stock?

On August 1, 2026, 9,957 RSUs vested and were converted into 9,957 shares of Zimmer Biomet common stock for Kevin R. Thornal. Each RSU represented a contingent right to receive one share of company common stock upon vesting.

How many Zimmer Biomet (ZBH) shares were withheld for taxes and at what price?

To satisfy tax withholding obligations on the RSU vesting, 4,266 shares of Zimmer Biomet common stock were withheld. These shares were valued at $92.68 per share, as reported under transaction code F for payment of tax liability using company stock.

What RSU vesting schedule remains for Kevin R. Thornal at Zimmer Biomet (ZBH)?

After the August 1, 2026 vesting, Kevin R. Thornal held 19,913 RSUs outstanding. The remaining RSUs are scheduled to vest in two equal installments, with one-half vesting on August 1, 2027 and one-half vesting on August 1, 2028.

Were Kevin R. Thornal’s ZBH transactions made under a Rule 10b5-1 plan?

The report indicates these transactions were not made under a Rule 10b5-1 trading plan. The document-level Rule 10b5-1 checkbox is marked as false, meaning the insider did not affirm that a pre-arranged trading plan governed these transactions.

What is Kevin R. Thornal’s role at Zimmer Biomet (ZBH) in this Form 4?

Kevin R. Thornal is reported as an officer of Zimmer Biomet, serving as Grp Pres-Global Business. The Form 4 reflects equity compensation activity related to his role, specifically RSU vesting, conversion into common stock, and associated tax withholding in company shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Thornal Kevin R

(Last)(First)(Middle)
345 E. MAIN STREET

(Street)
WARSAW INDIANA 46580

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Grp Pres-Global Business
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/01/2026M9,957A$09,957D
Common Stock08/01/2026F4,266(1)D$92.685,691D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(2)08/01/2026M9,957 (3) (3)Common Stock9,957$019,913D
Explanation of Responses:
1. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
2. Each RSU represents a contingent right to receive one share of Company common stock.
3. One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028.
/s/ Matthew R. St. Louis, Attorney-in-Fact for Kevin Thornal (power of attorney previously filed)08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)